| Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials RC Doebele, A Drilon, L Paz-Ares, S Siena, AT Shaw, AF Farago, ... The Lancet Oncology 21 (2), 271-282, 2020 | 1494 | 2020 |
| KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors DS Hong, MG Fakih, JH Strickler, J Desai, GA Durm, GI Shapiro, ... New England Journal of Medicine 383 (13), 1207-1217, 2020 | 1413 | 2020 |
| Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy J Garcia-Aguilar, S Patil, MJ Gollub, JK Kim, JB Yuval, HM Thompson, ... Journal of clinical oncology 40 (23), 2546-2556, 2022 | 512 | 2022 |
| Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines J Wang, S Saffold, X Cao, J Krauss, W Chen The Journal of Immunology 161 (10), 5516-5524, 1998 | 324 | 1998 |
| Rituximab extended schedule or re-treatment trial for low–tumor burden follicular lymphoma: Eastern Cooperative Oncology Group protocol E4402 BS Kahl, F Hong, ME Williams, RD Gascoyne, LI Wagner, JC Krauss, ... Journal of Clinical Oncology 32 (28), 3096-3102, 2014 | 230 | 2014 |
| Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial MG Fakih, S Kopetz, Y Kuboki, TW Kim, PN Munster, JC Krauss, ... The Lancet Oncology 23 (1), 115-124, 2022 | 220 | 2022 |
| Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074 JH Uhm, KV Ballman, W Wu, C Giannini, JC Krauss, JC Buckner, ... International Journal of Radiation Oncology* Biology* Physics 80 (2), 347-353, 2011 | 214 | 2011 |
| Systemic T cell adoptive immunotherapy of malignant gliomas GE Plautz, GH Barnett, DW Miller, BH Cohen, RA Prayson, JC Krauss, ... Journal of Neurosurgery 89 (1), 42-51, 1998 | 185 | 1998 |
| Efficacy and safety of entrectinib in patients with NTRK fusion-positive (NTRK-fp) tumors: pooled analysis of STARTRK-2, STARTRK-1 and ALKA-372-001 GD Demetri, L Paz-Ares, AF Farago, SV Liu, SP Chawla, D Tosi, ES Kim, ... Annals of oncology 29, viii713, 2018 | 162* | 2018 |
| Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fc gamma receptor IIIB and the complement receptor type 3. JC Krauss, PooH, W Xue, L Mayo-Bond, RF Todd 3rd, HR Petty Journal of immunology (Baltimore, Md.: 1950) 153 (4), 1769-1777, 1994 | 117 | 1994 |
| Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma DT Eitzman, JC Krauss, T Shen, J Cui | 113 | 1996 |
| Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study A Dasari, S Lonardi, R Garcia-Carbonero, E Elez, T Yoshino, A Sobrero, ... The Lancet 402 (10395), 41-53, 2023 | 108 | 2023 |
| Tubulogenesis from isolated single cells of adult mammalian kidney: clonal analysis with a recombinant retrovirus HD Humes, JC Krauss, DA Cieslinski, AJ Funke American Journal of Physiology-Renal Physiology 271 (1), F42-F49, 1996 | 108 | 1996 |
| Tumor immunology S Shu, GE Plautz, JC Krauss, AE Chang Jama 278 (22), 1972-1981, 1997 | 106 | 1997 |
| Isolation Based on l-Selectin Expression of Immune Effector T Cells Derived from Tumor-draining Lymph Nodes H Kagamu, JE Touhalisky, GE Plautz, JC Krauss, S Shu Cancer research 56 (19), 4338-4342, 1996 | 100 | 1996 |
| Interaction of Fcγ receptor type IIIB with complement receptor type 3 in fibroblast transfectants: evidence from lateral diffusion and resonance energy transfer studies H Poo, JC Krauss, L Mayo-Bond, RF Todd III, HR Petty Journal of molecular biology 247 (4), 597-603, 1995 | 99 | 1995 |
| Therapeutic efficacy of T cells derived from lymph nodes draining a poorly immunogenic tumor transduced to secrete granulocyte-macrophage colony-stimulating factor. MJ Arca, JC Krauss, A Aruga, MJ Cameron, S Shu, AE Chang Cancer gene therapy 3 (1), 39-47, 1996 | 95 | 1996 |
| Results of Eastern Cooperative Oncology Group Protocol E4402 (RESORT): a randomized phase III study comparing two different rituximab dosing strategies for low tumor burden … BS Kahl, F Hong, ME Williams, RD Gascoyne, LI Wagner, JC Krauss, ... Blood 118 (21), LBA-6, 2011 | 84 | 2011 |
| Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck: a phase 1 study WC To, BG Wood, JC Krauss, M Strome, RM Esclamado, P Lavertu, ... Archives of Otolaryngology–Head & Neck Surgery 126 (10), 1225-1231, 2000 | 82 | 2000 |
| Correction of CD18-deficient lymphocytes by retrovirus-mediated gene transfer JM Wilson, AJ Ping, JC Krauss, L Mayo-Bond, CE Rogers, DC Anderson, ... Science 248 (4961), 1413-1416, 1990 | 82 | 1990 |
Marwan FakihProfessor, City of Hope Comprehensive Cancer Center在 coh.org 的电子邮件经过验证
